New York State Common Retirement Fund’s Nuvectis Pharma NVCT Stock Holding History

New York State Common Retirement Fund’s Portfolio NVCT Stock Details NVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.6K	Hold	5,000	–	–	﹤0.01%	2889
2025 Q4	$37.8K	Hold	5,000	–	–	﹤0.01%	2979
2025 Q3	$30.1K	Sell	5,000 -8,000	-62%	-$55K	﹤0.01%	3054
2025 Q2	$97.1K	Buy	+13,000	New	+$118K	﹤0.01%	2693
2024 Q3	–	Sell	-64	Closed	-$405	–	3296
2024 Q2	$405	Sell	64 -5,685	-99%	-$38.6K	﹤0.01%	3351
2024 Q1	$47.1K	Sell	5,749 -23	-0.4%	-$196	﹤0.01%	2997
2023 Q4	$48.1K	Hold	5,772	–	–	﹤0.01%	3010
2023 Q3	$74.4K	Buy	5,772 +72	+1%	+$1.04K	﹤0.01%	2866
2023 Q2	$91K	Buy	+5,700	New	+$91K	﹤0.01%	2934

Other funds holding NVCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $165M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

New York State Common Retirement Fund's NVCT Position: Q1 2026 in Review

New York State Common Retirement Fund held its Nuvectis Pharma (NVCT) position steady in Q1 2026 at 5,000 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2889.

New York State Common Retirement Fund first reported a position in NVCT in Q2 2023 and has held it in 9 quarters since. The position peaked at $97.1K in Q2 2025. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

New York State Common Retirement Fund held 5,000 shares of Nuvectis Pharma worth $38.6K as of Q1 2026.
New York State Common Retirement Fund left its Nuvectis Pharma share count unchanged in Q1 2026.
Nuvectis Pharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #2889 holding.
New York State Common Retirement Fund first reported a position in Nuvectis Pharma in Q2 2023 and has held it in 9 quarters since.
New York State Common Retirement Fund's Nuvectis Pharma position peaked at $97.1K in Q2 2025.
62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.